BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 35934993)

  • 1. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
    Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
    Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of polypoid growth pattern with lymph node involvement in endometrioid type endometrial adenocarcinoma.
    Bezircioglu I; Yetimalar MH; Kilic D; Yigit S
    Indian J Cancer; 2023; 60(2):230-236. PubMed ID: 37530246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer.
    Liu Z; Lang J; Wu M; Li L
    Front Oncol; 2020; 10():618499. PubMed ID: 33665168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer.
    Nayyar N; Lakhwani P; Goel A; Pande PK; Kumar K
    Indian J Surg Oncol; 2018 Jun; 9(2):204-210. PubMed ID: 29887702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features related to lymphatic metastasis in grade 3 endometroid endometrial cancer: a retrospective cross-sectional study.
    Wang B; Wang Q; Shi Y; Shao WY; Liao JB; Luo XZ; Chen XJ; Wang C
    Chin Med J (Engl); 2021 Aug; 134(17):2102-2109. PubMed ID: 34435979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.
    Li H; Wang J; Zhang G; Li L; Shen Z; Zhai Z; Wang Z; Wang J
    Womens Health (Lond); 2024; 20():17455057241248398. PubMed ID: 38725247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer.
    Ocak B; Atalay FÖ; Sahin AB; Ozsen M; Dakiki B; Türe S; Mesohorli M; Odman HU; Tanrıverdi Ö; Ocakoğlu G; Bayrak M; Ozan H; Demiröz C; Sali S; Orhan SO; Deligönül A; Cubukcu E; Evrensel T
    Bosn J Basic Med Sci; 2021 Feb; 21(5):549-554. PubMed ID: 33714260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concept of tailored lymphadenectomy in endometrial cancer.
    Sakuragi N
    J Gynecol Oncol; 2012 Oct; 23(4):210-2. PubMed ID: 23094123
    [No Abstract]   [Full Text] [Related]  

  • 9. The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis.
    Fu R; Zhang D; Yu X; Zhang H
    Transl Cancer Res; 2022 Nov; 11(11):4159-4177. PubMed ID: 36523313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
    Koskas M; Rouzier R; Amant F
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):845-57. PubMed ID: 25817745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrial cancer - preoperative identification of low and high risk endometrial cancer (a review of the most recent ultrasound studies)].
    Fischerová D
    Ceska Gynekol; 2014 Dec; 79(6):456-65. PubMed ID: 25585554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictability of lymph node involvement in uterus-confined endometrioid endometrial cancer by tumour size, pattern and location measured with transvaginal ultrasonography: can we save time?
    Khatib G; Vardar MA; Güzel AB; Küçükgöz Güleç Ü; Köse S; Seyfettinoğlu S; Sucu M; Gümürdülü D
    J Obstet Gynaecol; 2022 Oct; 42(7):3142-3148. PubMed ID: 35934993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
    Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
    J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.